NO854576L - Cholecalciferolderivater. - Google Patents

Cholecalciferolderivater.

Info

Publication number
NO854576L
NO854576L NO854576A NO854576A NO854576L NO 854576 L NO854576 L NO 854576L NO 854576 A NO854576 A NO 854576A NO 854576 A NO854576 A NO 854576A NO 854576 L NO854576 L NO 854576L
Authority
NO
Norway
Prior art keywords
cholecalciferolderivater
Prior art date
Application number
NO854576A
Other languages
English (en)
Other versions
NO162906C (no
NO162906B (no
Inventor
Enrico Baggiolini
Giacomo Pizzolato
Milan Uskokovic
Gary Truitt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO854576L publication Critical patent/NO854576L/no
Publication of NO162906B publication Critical patent/NO162906B/no
Publication of NO162906C publication Critical patent/NO162906C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C7/00Purification; Separation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/44Halogenated unsaturated alcohols containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Analytical Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Water Supply & Treatment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO854576A 1984-11-16 1985-11-15 Analogifremgangsmaate ved fremstilling av delta22- ellerdelta23- 26,26,26,27,27,27- heksafluor-1alfa,25-dihydroksycholecalciferol. NO162906C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/672,059 US4613594A (en) 1984-11-16 1984-11-16 Fluorinated vitamin D3 compounds

Publications (3)

Publication Number Publication Date
NO854576L true NO854576L (no) 1986-05-20
NO162906B NO162906B (no) 1989-11-27
NO162906C NO162906C (no) 1990-03-07

Family

ID=24696990

Family Applications (1)

Application Number Title Priority Date Filing Date
NO854576A NO162906C (no) 1984-11-16 1985-11-15 Analogifremgangsmaate ved fremstilling av delta22- ellerdelta23- 26,26,26,27,27,27- heksafluor-1alfa,25-dihydroksycholecalciferol.

Country Status (21)

Country Link
US (1) US4613594A (no)
EP (1) EP0182298B1 (no)
JP (1) JPS61122237A (no)
KR (1) KR930007993B1 (no)
AR (1) AR242767A1 (no)
AT (1) ATE48412T1 (no)
AU (1) AU588012B2 (no)
CA (1) CA1286693C (no)
DE (1) DE3574587D1 (no)
DK (1) DK159652C (no)
ES (1) ES8801198A1 (no)
FI (1) FI84599C (no)
HU (1) HU194162B (no)
IE (1) IE58851B1 (no)
IL (1) IL77052A (no)
MC (1) MC1709A1 (no)
NO (1) NO162906C (no)
NZ (1) NZ214175A (no)
PH (1) PH21540A (no)
PT (1) PT81502B (no)
ZA (1) ZA858151B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63196556A (ja) * 1987-02-10 1988-08-15 Taisho Pharmaceut Co Ltd 含フツ素ビタミンd誘導体
AU5185790A (en) * 1989-02-16 1990-09-05 University Of Georgia Research Foundation, Inc., The Treatment of tibial dyschondroplasia
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンd▲下3▼類固型製剤
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5278155A (en) * 1991-06-05 1994-01-11 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and cell differentiation-inducing agent containing the same
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
EP0521550B1 (en) * 1991-07-05 1996-09-18 Duphar International Research B.V Vitamin D compound, method of preparing this compound and intermediate therefor
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
US5547947A (en) * 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
JPS57149224A (en) * 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4358406A (en) * 1981-07-27 1982-11-09 Wisconsin Alumni Research Foundation 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
EP0115314B1 (de) * 1983-01-28 1988-06-08 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von Cholecalciferolderivaten
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
US4505906A (en) * 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US4521410A (en) * 1984-05-03 1985-06-04 The General Hospital Corporation Vitamin D glycosyl orthoesters

Also Published As

Publication number Publication date
ES8801198A1 (es) 1987-12-16
FI854492A (fi) 1986-05-17
ES548910A0 (es) 1987-12-16
ATE48412T1 (de) 1989-12-15
HU194162B (en) 1988-01-28
NO162906C (no) 1990-03-07
IE58851B1 (en) 1993-11-17
KR860004073A (ko) 1986-06-16
AR242767A1 (es) 1993-05-31
FI854492A0 (fi) 1985-11-14
EP0182298A1 (de) 1986-05-28
FI84599C (fi) 1991-12-27
IL77052A (en) 1990-02-09
PT81502B (pt) 1988-03-03
AU588012B2 (en) 1989-09-07
JPS61122237A (ja) 1986-06-10
MC1709A1 (fr) 1986-09-22
FI84599B (fi) 1991-09-13
DK159652C (da) 1991-04-08
PH21540A (en) 1987-11-16
PT81502A (en) 1985-12-01
JPH051770B2 (no) 1993-01-11
DK524585A (da) 1986-05-17
DE3574587D1 (de) 1990-01-11
EP0182298B1 (de) 1989-12-06
ZA858151B (en) 1986-06-25
HUT39138A (en) 1986-08-28
NZ214175A (en) 1989-04-26
DK524585D0 (da) 1985-11-13
CA1286693C (en) 1991-07-23
AU5089885A (en) 1986-05-29
KR930007993B1 (ko) 1993-08-25
NO162906B (no) 1989-11-27
IE852875L (en) 1986-05-16
US4613594A (en) 1986-09-23
IL77052A0 (en) 1986-04-29
DK159652B (da) 1990-11-12

Similar Documents

Publication Publication Date Title
ATE41922T1 (de) Alkylsulfonamidophenylalkylamine.
DE3585265D1 (de) Fibronektinpraeparate.
DE3587525T2 (de) Stepmotor.
FI77959B (fi) Hushaolls- eller motsvarande koeksanordning.
FI854429A0 (fi) Braenslepatron.
FI840024A (fi) Instaellbart saengbotten.
NO165256C (no) Fjaerovervaakningsanordning.
FI854492A (fi) Kolekalsiferolderivat.
FI73926B (fi) Standardhastighetsregulator foer motorfordon.
DE3586085D1 (de) Antitumor-4-hydroxy-2-zyklopentenonen.
FI80907B (fi) Kraftunderstoedd hudappliseringsapparat.
DE3587711D1 (de) Minaktivin.
FI83368B (fi) Handelvapen.
DE3576291D1 (de) Entaester.
FI853920L (fi) Foerbaettrad roterande staellning.
DE3587308D1 (de) Monobactame.
FI73513B (fi) Spiralsammanfogat ventilationsroer.
DE3585189D1 (de) Alpha-d-mannosidase hemmungsmittel.
FI844085A0 (fi) Tryckreduceringskammare foer ventilationsanordningar.
FI863301A0 (fi) Laosningsanordning.
ATE45742T1 (de) Hydrazon-substituierte peneme.
FI73502B (fi) Drivmekanism foer propellerpump.
ATE42307T1 (de) Epoxysteroide.
ATE61336T1 (de) Homopropargylamine.
ES277185Y (es) Sortijero.